Literature DB >> 8193061

Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness.

L Marsh1, R L Suddath, N Higgins, D R Weinberger.   

Abstract

Reductions in the size of medial temporal lobe structures in schizophrenia have been demonstrated using magnetic resonance imaging. It is not clear whether these neuropathological changes are present premorbidly or if they reflect an adult-onset progressive process. In this study, quantitative measures were made of the lateral ventricles, third ventricle, amygdala, hippocampus, and cerebral hemispheres from coronal MRI images on 33 patients with schizophrenia and 41 normal controls. Images were selected a priori from the region of the temporal lobe in which we had previously demonstrated reduced volume of temporal lobe gray matter in a separate sample of patients. Results showed a decrease in amygdala, hippocampal, and amygdala-hippocampal size bilaterally and an increase in third and lateral ventricular volume. Advancing age in normals was associated with a decrease in the size of medial temporal structures and an increase in lateral ventricular size. In schizophrenia, there was a correlation between age and lateral ventricle size, but duration of illness was not associated with reductions in medial temporal tissue or ventricular enlargement. These results are consistent with prior evidence from neuroimaging and postmortem studies of medial temporal pathology in schizophrenia and support hypotheses that neuropathological changes in schizophrenia are not progressive.

Entities:  

Mesh:

Year:  1994        PMID: 8193061     DOI: 10.1016/0920-9964(94)90016-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

Review 1.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

2.  Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data.

Authors:  Martha E Shenton; Guido Gerig; Robert W McCarley; Gábor Székely; Ron Kikinis
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

4.  Smaller left Heschl's gyrus volume in patients with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Melissa Frumin; Margaret A Niznikiewicz; Yoshio Hirayasu; Stephanie Fraone; Larry J Seidman; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

Review 5.  Towards a functional neuroanatomy of conscious perception and its modulation by volition: implications of human auditory neuroimaging studies.

Authors:  D A Silbersweig; E Stern
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-11-29       Impact factor: 6.237

6.  An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia.

Authors:  Jane E Anderson; Cynthia G Wible; Robert W McCarley; Marianna Jakab; Kiyoto Kasai; Martha E Shenton
Journal:  Schizophr Res       Date:  2002-12-01       Impact factor: 4.939

Review 7.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  A case study of temporal lobe development in familial schizophrenia.

Authors:  W G Honer; A S Bassett; P Falkai; T G Beach; J S Lapointe
Journal:  Psychol Med       Date:  1996-01       Impact factor: 7.723

Review 9.  Totally tubular: the mystery behind function and origin of the brain ventricular system.

Authors:  Laura Anne Lowery; Hazel Sive
Journal:  Bioessays       Date:  2009-04       Impact factor: 4.345

10.  Neuronal degeneration in canine narcolepsy.

Authors:  J M Siegel; R Nienhuis; S Gulyani; S Ouyang; M F Wu; E Mignot; R C Switzer; G McMurry; M Cornford
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.